» Articles » PMID: 37129023

Hepatoprotective Effect of Protocatechuic Acid Against Type 2 Diabetes-induced Liver Injury

Overview
Journal Pharm Biol
Specialties Pharmacology
Pharmacy
Date 2023 May 2
PMID 37129023
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Protocatechuic acid (PCA) has a protective effect on alcoholic liver injury, but the role of PCA in type 2 diabetes-induced liver injury is not well known.

Objectives: This study explores the therapeutic effect and potential mechanism of PCA on type 2 diabetes-induced liver injury.

Materials And Methods: An insulin resistance/type 2 diabetic (IR/D) model was established by high-fat diet for 4 weeks + streptozotocin (35 mg/kg; i.p) in male Wistar rats pretreated with or without PCA (15 or 30 mg/kg for 6 d).

Results: PCA at 15 and 30 mg/kg significantly upregulated the levels of body weight (BW; 230.2, 257.8 g), high density lipids (22.68, 34.78 mg/dL), glutathione (10.24, 16.21 nmol/mg), superoxide dismutase (21.62, 29.34 U/mg), glucagon-like peptide-1, glucose transporter-4, Wnt1, and β-catenin, while downregulating those of liver weight (LW; 9.4, 6.7 g), BW/LW (4.1, 2.6%), serum glucose (165, 120 mg/dL), serum insulin (13.46, 8.67 μIU/mL), homeostatic model assessment of insulin resistance (5.48, 2.57), total cholesterol (68.52, 54.31 mg/dL), triglycerides (72.15, 59.64 mg/dL), low density lipids (42.18, 30.71), aspartate aminotransferase (54.34 and 38.68 U/L), alanine aminotransferase (42.87, 29.98 U/L), alkaline phosphatase (210.16, 126.47 U/L), malondialdehyde (16.52, 10.35), pro-inflammatory markers (tumor necrosis factor α (TNF-α (149.67, 120.33 pg/mg)) , IL-6 (89.79, 73.69 pg/mg) and IL-1β (49.67, 38.73 pg/mg)), nuclear factor kappa B (NF-κB), and interleukin-1β, and ameliorated the abnormal pathological changes in IR/D rats.

Discussion And Conclusion: PCA mitigates the IR, lipid accumulation, oxidative stress, and inflammation in liver tissues of IR/D rats by modulating the NF-κB and Wnt1/β-catenin pathways.

Citing Articles

Wnt1 oversees microglial activation by the Wnt/LRP5/6 receptor signaling pathway during lipopolysaccharide-mediated toxicity.

Qing W, Hao X, Xuan S, Zhihui R, Jinzhi G Mol Biol Rep. 2025; 52(1):273.

PMID: 40025242 PMC: 11872766. DOI: 10.1007/s11033-025-10360-2.


Study on the protective effect of extract on type 2 diabetes by regulating glucose and lipid metabolism through intestinal flora.

Song D, Fang C Food Sci Nutr. 2024; 12(10):7620-7629.

PMID: 39479662 PMC: 11521703. DOI: 10.1002/fsn3.4378.


Banxia Xiexin Tang attenuates high glucose-induced hepatocyte injury by activating SOD2 to scavenge ROS via PGC-1α/IGFBP1.

Yang X, Yue R, Zhao L, Huang X, Wang Q 3 Biotech. 2024; 14(9):216.

PMID: 39220826 PMC: 11358567. DOI: 10.1007/s13205-024-04060-0.

References
1.
Kassab R, Theyab A, Al-Ghamdy A, Algahtani M, Mufti A, Alsharif K . Protocatechuic acid abrogates oxidative insults, inflammation, and apoptosis in liver and kidney associated with monosodium glutamate intoxication in rats. Environ Sci Pollut Res Int. 2021; 29(8):12208-12221. DOI: 10.1007/s11356-021-16578-4. View

2.
Bhardwaj R, Singh B, Sandhu N, Singh N, Kaur R, Rokana N . Probiotic mediated NF-κB regulation for prospective management of type 2 diabetes. Mol Biol Rep. 2020; 47(3):2301-2313. DOI: 10.1007/s11033-020-05254-4. View

3.
Anwar S, Khan S, Almatroudi A, Khan A, Alsahli M, Almatroodi S . A review on mechanism of inhibition of advanced glycation end products formation by plant derived polyphenolic compounds. Mol Biol Rep. 2021; 48(1):787-805. DOI: 10.1007/s11033-020-06084-0. View

4.
Younus H, Anwar S . Prevention of non-enzymatic glycosylation (glycation): Implication in the treatment of diabetic complication. Int J Health Sci (Qassim). 2016; 10(2):261-77. PMC: 4825899. View

5.
Ma R . Epidemiology of diabetes and diabetic complications in China. Diabetologia. 2018; 61(6):1249-1260. DOI: 10.1007/s00125-018-4557-7. View